Patent · US Active

Protein-based T-cell receptor knockdown

US10730942B2 · kind B2 · utility

11Cited by
12References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2017
Grant dateAug 4, 2020
Priority date—
Expiry dateJul 24, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/10043
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to protein-based T-cell receptor knockdown, and its use in T-cell therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.